Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02640118Completed
Randomised, double-blind trial of lixisenatide in postpancreatectomy diabetes mellitus (2 cohorts), sponsored by Gentofte Hospital. Primary endpoint: Postprandial Glucose Excursions (Incremental Area Under Curve) at 180 minutes. Started Aug 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02640118.